+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Congestive Heart Failure Treatment Device Market by Device Type, Therapeutic Modality, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Congestive Heart Failure Treatment Device Market by Device Type, Therapeutic Modality, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Congestive Heart Failure Treatment Device Market by Device Type, Therapeutic Modality, End User, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995113
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Congestive Heart Failure Treatment Device Market is projected to reach USD 24.30 Billion in 2026. It is expected to continue growing at a CAGR of 16.29%, reaching USD 60.35 Billion by 2032.

Congestive heart failure (CHF) treatment devices are becoming central to cardiovascular care as aging populations, hypertension, diabetes, ischemic heart disease, chronic kidney disease, and improved survival after cardiac events expand the heart failure burden. The device landscape spans cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), ventricular assist devices (VADs), implantable and wearable hemodynamic monitoring systems, ultrafiltration technologies, remote patient monitoring platforms, and connected post-discharge management tools.

Demand is supported by guideline-directed care, rising hospitalization costs, and payer interest in reducing preventable readmissions. The World Health Organization identifies cardiovascular disease as the leading global cause of death, while U.S. public health data show heart failure affects millions of adults and drives substantial medical spending, making CHF treatment devices a high-priority category for hospitals, payers, medtech manufacturers, and digital health innovators.

Transformative Shifts in CHF Device Care

The CHF treatment device landscape is shifting from episodic intervention toward continuous, data-enabled disease management. Hospitals increasingly evaluate devices not only by procedural performance but also by their ability to support longitudinal monitoring, medication optimization, fewer decompensation events, earlier escalation of care, and improved quality of life.

Transformative forces include miniaturized implantables, remote pulmonary artery and pressure monitoring, rechargeable and longer-life batteries, less invasive VAD implantation pathways, home-based monitoring, and value-based reimbursement. Regulatory pathways are also emphasizing real-world evidence, cybersecurity, interoperability, human factors, and post-market surveillance, raising the competitive importance of clinically validated outcomes.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the move from reactive CHF treatment to predictive care. AI-enabled analytics can combine device telemetry, weight, blood pressure, rhythm data, activity trends, laboratory values, medication history, and electronic health record signals to identify deterioration risk before symptoms trigger an emergency visit.

Its cumulative impact is strongest where algorithms are embedded into clinician workflows rather than deployed as standalone dashboards. Validated AI can improve triage, reduce alert fatigue, personalize device programming, support advanced therapy selection, improve remote cardiac care, and strengthen population-level risk stratification, while requiring transparent validation, bias monitoring, explainability, cybersecurity safeguards, and compliance with medical device software regulations.

Key Regional Insights for CHF Treatment Devices

North America remains a leading region for CHF treatment devices due to high diagnosed heart failure prevalence, advanced electrophysiology and heart failure programs, Medicare coverage pathways, specialist access, and early adoption of implantable monitoring and mechanical circulatory support. Europe benefits from established cardiac device reimbursement, strong clinical research networks, and European Union regulatory harmonization, although cost-containment pressures, health technology assessment requirements, and procurement scrutiny shape adoption across hospitals.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in cardiac care capacity, local manufacturing, tertiary hospitals, and connected health infrastructure. Latin America shows rising demand in Brazil and Mexico, supported by private hospital networks, urban specialty care, and increasing cardiovascular risk from hypertension, diabetes, and obesity. The Middle East is investing in tertiary cardiac centers, digital health programs, and high-acuity specialty care, while Africa’s opportunity is tied to access expansion, workforce training, affordable diagnostics, and scalable remote monitoring solutions for under-resourced cardiac systems.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Across ASEAN, CHF device adoption is supported by expanding private healthcare, medical tourism hubs, urban cardiology centers, and government efforts to strengthen chronic disease management, although reimbursement variability and uneven specialist distribution limit uniform uptake. The GCC is investing in specialty cardiac centers, national digital health systems, and advanced hospital infrastructure, making remote monitoring, premium implantables, and high-acuity heart failure pathways relevant to regional care delivery.

The European Union provides scale through shared regulatory frameworks, strong evidence standards, and coordinated health technology assessment priorities, while BRICS countries combine large patient populations with increasing domestic medtech capacity and demand for cost-effective cardiac devices. G7 markets lead in advanced implants, VAD programs, remote monitoring integration, and evidence generation. NATO economies, many overlapping with G7 and EU members, benefit from resilient procurement systems, cybersecurity priorities, interoperable digital infrastructure, and established cardiovascular care networks for connected cardiac devices.

Key Country Insights for CHF Treatment Device Adoption

The United States is the largest innovation and reimbursement anchor, with strong uptake of ICDs, CRT, remote monitoring, and VADs supported by advanced heart failure centers and public-private payer coverage. Canada emphasizes evidence-based access and provincial reimbursement, while Mexico and Brazil are important Latin American growth markets with expanding private cardiovascular care and increasing chronic disease burden. The United Kingdom, Germany, France, Italy, and Spain sustain demand through advanced cardiac centers, national guideline alignment, and established electrophysiology services, though budget scrutiny and technology assessment processes affect purchasing cycles.

Russia remains a specialized device market influenced by localization policies and access constraints. China is scaling domestic production, tertiary cardiac care, and digital hospital infrastructure, while India is driven by high disease burden, affordability needs, and the expansion of cardiac specialty hospitals. Japan emphasizes advanced aging-related care and sophisticated implantable device management, Australia supports structured cardiac services through specialist networks, and South Korea combines digital health capability, strong hospital infrastructure, and advanced cardiovascular care adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated differentiation, particularly devices that reduce heart failure hospitalization, support remote management, improve functional status, and integrate with guideline-directed medical therapy. Evidence strategies should include real-world outcomes, health economic endpoints, subgroup performance, durability data, safety surveillance, and usability findings for clinicians, caregivers, and patients.

Manufacturers should build interoperable platforms, strengthen cybersecurity, localize pricing for emerging markets, and partner with hospitals on service models that support implantation, monitoring, follow-up, and patient adherence. Commercial teams should align messaging to payers, electrophysiologists, heart failure specialists, cardiac surgeons, procurement leaders, and home-care providers, emphasizing total cost of care, workflow fit, fewer avoidable admissions, and measurable patient outcomes.

Research Methodology

This executive summary is based on secondary research from public health agencies, peer-reviewed cardiovascular literature, clinical practice guidelines, regulatory frameworks, reimbursement references, hospital technology assessment materials, and medtech industry reporting. Sources include established organizations such as WHO, CDC, AHA/ACC/HFSA, ESC, FDA, EMA, and national health authorities where applicable.

The analysis applies triangulation across disease burden, procedure trends, technology adoption, reimbursement environment, regulatory direction, clinical utility, and regional healthcare infrastructure. Insights are validated through consistency checks across epidemiology, guideline recommendations, safety evidence, post-market requirements, and procurement behavior to support reliable focused market interpretation without relying on market sizing, market share, or forecasting.

Conclusion

The CHF treatment device market is moving toward integrated, intelligence-enabled cardiac care that connects implants, monitoring, analytics, and clinical workflows. Adoption will be shaped by the ability to demonstrate fewer hospitalizations, better functional status, safer long-term support, durable device performance, and sustainable economics.

Organizations that combine robust evidence, interoperable design, AI-enabled risk detection, cybersecurity readiness, and regionally adapted access models are best positioned to address demand. As heart failure remains a major global health challenge, treatment devices will play an increasingly important role in precision cardiovascular management and long-term patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Congestive Heart Failure Treatment Device Market, by Device Type
7.1. Cardiac Resynchronization Therapy Device
7.2. Implantable Cardioverter Defibrillator
7.3. Ventricular Assist Device
7.3.1. Biventricular Assist Device
7.3.2. Left Ventricular Assist Device
7.3.3. Right Ventricular Assist Device
8. Congestive Heart Failure Treatment Device Market, by Therapeutic Modality
8.1. Electrical Stimulation
8.1.1. Asynchronous Pacemakers
8.1.2. Synchronous Pacemakers
8.2. Mechanical Circulatory Support
9. Congestive Heart Failure Treatment Device Market, by End User
9.1. Ambulatory Surgical Centers
9.2. Hospitals
9.3. Specialty Clinics
10. Congestive Heart Failure Treatment Device Market, by Distribution Channel
10.1. Direct Sales
10.2. Distributors
10.3. Online Sales
11. Asia-Pacific Congestive Heart Failure Treatment Device Market
12. Europe Congestive Heart Failure Treatment Device Market
13. North America Congestive Heart Failure Treatment Device Market
14. Latin America Congestive Heart Failure Treatment Device Market
15. Africa Congestive Heart Failure Treatment Device Market
16. Middle East Congestive Heart Failure Treatment Device Market
17. NATO Congestive Heart Failure Treatment Device Market
18. G7 Congestive Heart Failure Treatment Device Market
19. BRICS Congestive Heart Failure Treatment Device Market
20. European Union Congestive Heart Failure Treatment Device Market
21. ASEAN Congestive Heart Failure Treatment Device Market
22. GCC Congestive Heart Failure Treatment Device Market
23. China Congestive Heart Failure Treatment Device Market
24. United States Congestive Heart Failure Treatment Device Market
25. Japan Congestive Heart Failure Treatment Device Market
26. India Congestive Heart Failure Treatment Device Market
27. Germany Congestive Heart Failure Treatment Device Market
28. United Kingdom Congestive Heart Failure Treatment Device Market
29. Australia Congestive Heart Failure Treatment Device Market
30. France Congestive Heart Failure Treatment Device Market
31. South Korea Congestive Heart Failure Treatment Device Market
32. Italy Congestive Heart Failure Treatment Device Market
33. Canada Congestive Heart Failure Treatment Device Market
34. Russia Congestive Heart Failure Treatment Device Market
35. Brazil Congestive Heart Failure Treatment Device Market
36. Mexico Congestive Heart Failure Treatment Device Market
37. Spain Congestive Heart Failure Treatment Device Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. Abbott Laboratories
39.2. Abiomed, Inc.
39.3. Ancora Heart, Inc.
39.4. Berlin Heart GmbH
39.5. Biotronik SE & Co. KG
39.6. Boston Scientific Corporation
39.7. CardiacAssist, Inc.
39.8. Cook Medical LLC
39.9. CorWave SA
39.10. CVRx, Inc.
39.11. Edwards Lifesciences Corporation
39.12. Getinge AB
39.13. Jarvik Heart Inc.
39.14. Lepu Medical Technology Co., Ltd.
39.15. LivaNova PLC
39.16. MEDICO S.p.A.
39.17. Medtronic plc
39.18. MicroPort Scientific Corporation
39.19. OSCOR Inc.
39.20. Osypka Medical GmbH
39.21. Otsuka Pharmaceutical Co., Ltd.
39.22. ReliantHeart, Inc.
39.23. Shree Pacetronix Ltd.
39.24. SynCardia Systems LLC
39.25. Terumo Corporation
39.26. Vitatron B.V.
39.27. W. L. Gore & Associates, Inc.
39.28. Zoll Medical Corporation
List of Figures
FIGURE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 62. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 63. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 64. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 65. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 69. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 70. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 71. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 72. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 73. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 90. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 91. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 92. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 93. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 104. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 105. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 106. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 107. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 111. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 112. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 113. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 114. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 118. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 119. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 120. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 121. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 132. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 133. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 134. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 135. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 139. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 140. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 141. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 142. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 145. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 146. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 147. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 148. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 149. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 152. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 153. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 159. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 160. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 161. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 162. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 163. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 166. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 167. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 168. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 169. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 170. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 174. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 175. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 176. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 177. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 180. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 181. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 183. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 184. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 187. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 188. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 189. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 190. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 191. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 195. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 196. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 197. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 198. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 201. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 202. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 203. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 204. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 205. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 208. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 209. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 210. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 211. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 212. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 216. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 217. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 218. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 219. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 222. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 223. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 224. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 225. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 226. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 229. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 230. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 231. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 232. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 233. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 235. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 237. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 238. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 239. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 240. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 244. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 245. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
TABLE 246. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
TABLE 247. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Congestive Heart Failure Treatment Device market report include:
  • Abbott Laboratories
  • Abiomed, Inc.
  • Ancora Heart, Inc.
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardiacAssist, Inc.
  • Cook Medical LLC
  • CorWave SA
  • CVRx, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Jarvik Heart Inc.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • MEDICO S.p.A.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • OSCOR Inc.
  • Osypka Medical GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • ReliantHeart, Inc.
  • Shree Pacetronix Ltd.
  • SynCardia Systems LLC
  • Terumo Corporation
  • Vitatron B.V.
  • W. L. Gore & Associates, Inc.
  • Zoll Medical Corporation

Table Information

Report AttributeDetails
No. of Pages195
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 24.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 60.35 Billion
Compound Annual Growth Rate16.2%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Congestive Heart Failure (CHF) Treatment Devices - Global Strategic Business Report - Product Image

Congestive Heart Failure (CHF) Treatment Devices - Global Strategic Business Report

  • Report
  • 177 Pages
  • Global
From
Congestive Heart Failure Treatment Devices Market Report 2026 - Product Image

Congestive Heart Failure Treatment Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Congestive Heart Failure Treatment Devices: Market Share, and Growth Analysis by Product Type (Implantable Devices, External Devices), Application, End User, Technology - Product Image

Congestive Heart Failure Treatment Devices: Market Share, and Growth Analysis by Product Type (Implantable Devices, External Devices), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Congestive Heart Failure (CHF) Treatment Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Congestive Heart Failure (CHF) Treatment Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 132 Pages
  • Global
From
a-Acetyldigitoxin Market - Global Forecast 2026-2032 - Product Image

a-Acetyldigitoxin Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From

About the Congestive Heart Failure Device Market

The Congestive Heart Failure Device market is a subset of the Cardiovascular Devices market. It includes a range of devices used to treat congestive heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These devices include implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and left ventricular assist devices (LVADs). These devices are designed to improve the quality of life of patients with congestive heart failure by providing support to the heart and helping to regulate its rhythm. Some of the major companies in the Congestive Heart Failure Device market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and LivaNova. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.